Vertex Pharmaceuticals Incorporated

Healthcare · Biotechnology · United States

Last price 558.88 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 141.65B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMK...